genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Genetic Disease Testing
Multiomics Approach Improves Diagnosis of Rare Disease, Methylmalonic Aciduria
Base Editing
Zinc Finger Design AI Tool Opens Door to Large-Scale Gene Therapies
Cancer
Multidrug Nanoparticle Platform Improves Drug Delivery against Cancer
Cancer
Cancer’s Capacity to Resist Treatment Thwarted
Animal Models
Microbiome and its Metabolites Promote Endometriosis in Animal Model
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Artificial Intelligence
Chiral Spectroscopy Lessens the Chiral Resolution Stumbling Block
Antibodies
Advanced Therapies Could Be Sleepwalking into a Manufacturing Cost Crisis
Bioprocessing
Cell and Gene Therapy Scale-Up Challenges
Bioprocessing
Making Molecules Instead of Growing Them
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Home
Therapeutics
Orphan Drugs
Orphan Drugs
Anti-Ulcerants
Antibacterials
Antibiotics
Anticoagulants
Antidiabetics
Antifungals
Antivirals
Autoimmune Disease Drugs
Biologics
Biosimilars
Cardiovascular Drugs
Cellular Therapeutics
Combination Therapies
Dermatologic Drugs
Enzyme Replacement Therapy
Generics
Hormone Replacement Therapy
Immuno-oncology
Immunotherapies
Lipid Regulators
Mental Health Drugs
Oncologics
Orphan Drugs
Pain
Protein Therapeutics
Psychoactive Drugs
Radiopharmaceuticals
Respiratory Drugs
Traditional Chinese Medications
Vaccines
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Orphan Drugs
Advanced Therapies Lead to Supply Chain Complexity
Musculoskeletal Disorders
Same Drug, New Partner: Capricor in Up-to-$735M Deal for DMD Cell Therapy
Orphan Drugs
Global Blood Therapeutics CEO Defends Price of Sickle-Cell Drug Oxbryta
Orphan Drugs
Fetal Gene Therapy Prevents Fatal Form of Gaucher Disease
Orphan Drugs
United Therapeutics to Acquire SteadyMed for Up to $216M
Orphan Drugs
Novartis to Acquire Gene Therapy Developer AveXis for $8.7B
Orphan Drugs
PhaseBio Wins $2.8M SBIR Grant to Advance Lead Candidate
Orphan Drugs
Erytech, Queen’s Partner to Develop Red Blood Cell-Encapsulated Enzyme Therapy
Orphan Drugs
FDA Commits to Eliminating Orphan Drug Backlog by September
Orphan Drugs
FDA Approves CSL Behring’s Self-Administered C1 Esterase Inhibitor HAE Prophylactic
Orphan Drugs
TeneoBio, Selexis Sign SUREtechnology Cell-Line Agreement for Anticancer UniAbs
Orphan Drugs
Mithra’s E4 Estrogen Wins EU Orphan Drug Designation for Treating HIE...
Orphan Drugs
Start-Up Firm Palladio to Repurpose Lixivaptan as Treatment for PKD
Orphan Drugs
Shire Plans Lanadelumab BLA Submission Following Positive Phase III HAE Results
Orphan Drugs
Synlogic, Mirna Agree to Stock-Based Merger to Focus on Synthetic Biotic...
1
2
3
Page 1 of 3
Scroll Up
Login
Subscribe